找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Nanoparticle-Mediated Immunotherapy; Tuan Vo-Dinh Book 2021 Springer Nature Switzerland AG 2021 multifunction nanoparticles in medicine.ca

[復(fù)制鏈接]
樓主: 味覺沒有
21#
發(fā)表于 2025-3-25 04:23:23 | 只看該作者
Development of Nanoparticles as a Vaccine Platform. In recent years, due to climate and environmental changes, inoculation against various infectious diseases has become increasingly important. When purified proteins or peptides are used as an antigen for inoculation, the effectiveness of the vaccination is often insufficient. To strengthen the imm
22#
發(fā)表于 2025-3-25 08:25:09 | 只看該作者
23#
發(fā)表于 2025-3-25 14:31:24 | 只看該作者
24#
發(fā)表于 2025-3-25 19:02:12 | 只看該作者
Bioanalysishttp://image.papertrans.cn/n/image/660861.jpg
25#
發(fā)表于 2025-3-25 21:35:55 | 只看該作者
https://doi.org/10.1007/978-3-030-78338-9multifunction nanoparticles in medicine; cancer nanotechnology; nanoparticle cancer treatment; nanomedi
26#
發(fā)表于 2025-3-26 00:51:53 | 只看該作者
27#
發(fā)表于 2025-3-26 07:01:55 | 只看該作者
Nanoparticle-Mediated Immunotherapy978-3-030-78338-9Series ISSN 2364-1118 Series E-ISSN 2364-1126
28#
發(fā)表于 2025-3-26 10:02:28 | 只看該作者
2364-1118 ls, and systems design.Focuses on clinical potential and tra.This book is intended to serve as an authoritative reference source for a broad audience involved in the research, teaching, learning, and practice of nanotechnology in immunotherapy. The combination of nanotechnology and immunotherapy is
29#
發(fā)表于 2025-3-26 12:47:48 | 只看該作者
Multifunctional Gold Nanostars for Sensitive Detection, Photothermal Treatment and Immunotherapy of i-cancer immune response, “Cancer Vaccine” effect, to prevent cancer recurrence. Therefore, the biocompatible GNS nanoparticles have the promise for future clinical translation to improve brain cancer diagnostics and therapeutics.
30#
發(fā)表于 2025-3-26 17:18:44 | 只看該作者
Immunotherapy: From Discovery to Bedsides for new treatments in the immune-oncology space. Herein we review the broad categories of immunotherapy, as well as discuss the pathway(s) for bringing promising treatments to the clinic. Challenges posed by immune-oncology therapies have led to shifts in approaches to clinical trials and we will discuss these as well.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 16:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南开区| 肥乡县| 车致| 奉化市| 时尚| 萨嘎县| 福建省| 寿宁县| 金寨县| 通山县| 浠水县| 伊春市| 西乡县| 东兰县| 星子县| 呼和浩特市| 东城区| 农安县| 元阳县| 孙吴县| 宜章县| 鄂伦春自治旗| 汾阳市| 泸溪县| 苏尼特左旗| 卢湾区| 武定县| 大余县| 黑山县| 湄潭县| 嵊泗县| 上林县| 迁安市| 安阳市| 黄大仙区| 和硕县| 亳州市| 漳平市| 巴中市| 安塞县| 政和县|